# CNBX Pharmaceuticals Inc. (CNBX)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/CNBX/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -44.1K | $ -30.5K | N/A | $ -2.53M |
| 2025 | $ 0 | $ -402.7K | $ -183.9K | $ 1.25M | $ -2.57M |
| 2024 | $ 42.7K | $ -579.1K | $ -222.3K | $ 1.33M | $ -2.51M |
| 2023 | $ 540.2K | $ -3.82M | $ -96.9K | $ 1.31M | $ -2.09M |
| 2022 | $ 33.5K | $ -3.65M | $ -1.32M | $ 1.76M | $ -1.97M |
| 2021 | $ 0 | $ -4.59M | $ -2.97M | $ 1.07M | $ 627.4K |
| 2020 | $ 6.9K | $ -3.80M | $ -3.40M | $ 0 | $ 1.26M |
| 2019 | $ 10.7K | $ -4.33M | $ -4.31M | $ 0 | $ 6.02M |
| 2018 | $ 14.7K | $ -5.14M | $ -4.23M | $ 0 | $ 9.07M |
| 2017 | $ 10.0K | $ -3.13M | $ -1.75M | $ 0 | $ 2.42M |
| 2016 | $ 154.8K | $ -535.1K | $ -318.6K | $ 0 | $ -230.5K |
| 2015 | $ 0 | $ -659.0K | $ -142.1K | $ 20.0K | $ 157.3K |
| 2014 | $ 0 | $ -543.6K | $ -422.4K | $ 0 | $ 4.42M |
| 2013 | $ 0 | $ -77.7K | $ -104.2K | $ 0 | $ -18.7K |
| 2012 | $ 0 | $ -9.4K | $ 5.0K | $ 0 | $ -64.1K |
| 2011 | $ 0 | $ -270.1K | $ 1.50M | $ 0 | $ -57.6K |
| 2010 | $ 0 | $ -155.8K | $ 213.8K | $ 0 | $ 51.2K |
| 2009 | $ 0 | $ -197.7K | $ -197.3K | $ 0 | $ 154.1K |
| 2008 | $ 0 | $ -38.9K | $ -14.5K | $ 0 | $ 284.4K |
| 2007 | $ 0 | $ -34.8K | $ -26.1K | $ 0 | $ 310.1K |
| 2006 | $ 0 | $ -24.0K | $ -30.7K | $ 25.0K | $ 334.7K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Liabilities / Eq | -1.01 |
| Current Ratio | 0.01 |

## Other views

- [Metrics](https://sponda.capital/en/CNBX.md)
- [Charts](https://sponda.capital/en/CNBX/charts.md)
- [Compare](https://sponda.capital/en/CNBX/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.